Cite

HARVARD Citation

    Wei, S. et al. (2022). Genome editing of PD-L1 mediated by nucleobase-modified polyamidoamine for cancer immunotherapy. Journal of materials chemistry. 10 (8), pp. 1291-1300. [Online]. 
  
Back to record